Skip to content

Genetic Susceptibility to Kidney Cancer

Genetic Susceptibility to Renal Cell Carcinoma

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00854022
Enrollment
6
Registered
2009-03-02
Start date
2008-07-31
Completion date
2013-03-31
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Carcinoma

Brief summary

This study will further the understanding of the genetic events leading to the development of RCC.

Detailed description

This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and eventually provide a means of identifying a subgroup of individuals who are most likely to develop RCC. Such individuals may then be targeted for intervention programs such as chemoprevention or dietary modification.

Interventions

None listed

Sponsors

M.D. Anderson Cancer Center
CollaboratorOTHER
Baylor College of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year.

Exclusion criteria

* Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will * Must not have had RCC, or metastatic RCC, * Must not have had a renal transplantation

Design outcomes

Primary

MeasureTime frame
To identify interindividual differences in inherited genetic instability12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026